SCHEMBL26601846

SCHEMBL26601846

Cc1cc(C(C)(C)C)c(Cl)cc1-c1cc(=O)c(-c2cnccn2)c(C)[nH]1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.32
▸ KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30624653 1.00 NPY5R (0.32) NPY5RKDR
SCHEMBL26602678 0.80 KDM5B (0.33) —
SCHEMBL26676188 0.80 CLK2 (0.33) NPY5R
SCHEMBL30695289 0.80 CLK2 (0.33) NPY5R
SCHEMBL26601592 0.79 EZH2 (0.36) —
SCHEMBL26707612 0.79 ADORA2A (0.33) —
SCHEMBL26601605 0.78 ADRA2A (0.32) —
SCHEMBL26601579 0.78 IDO1 (0.33) —
SCHEMBL30624550 0.77 KMO (0.35) KDR
SCHEMBL26601926 0.77 KMO (0.35) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4511117-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 — — EP disclosed
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback